Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 82-89, January 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heal, J. M.
Right arrow Articles by Schein, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heal, J. M.
Right arrow Articles by Schein, P. S.

Effect of Carbamoylation on the Repair of Nitrosourea-induced DNA Alkylation Damage in L1210 cells1

Joanna M. Heal, Patricia A. Fox and Philip S. Schein2

Division of Medical Oncology, Vincent T. Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, D. C. 20007

The effect of nitrosourea carbamoylating activity on the repair of nitrosourea-induced DNA alkylation damage has been evaluated. Two methylnitrosoureas were investigated; streptozotocin, a C-2 glucose-substituted methylnitrosourea, and 3-ß-D-glucopyranosyl-1-methyl-1-nitrosourea (GMNU), a C-1 glucose analog. Streptozotocin has an alkylating activity (100%) similar to that of GMNU (92%) but a widely differing carbamoylating activity (streptozotocin produced 3% carbamoylation of [14C]lysine versus 42% produced by GMNU). L1210 cells after a 2-hr 0.5 mM incubation showed equivalent single-strand breaks, 1.77 ± 0.13 (S.E.)/1 x 109 daltons with streptozotocin and 1.67 ± 0.03 for GMNU, measured by alkaline sucrose gradients. Following streptozotocin, full repair of these lesions was documented 8 hr after drug removal. In contrast, the repair of GMNU-induced damage was not complete for 12 hr. The cytotoxicity of the two drugs for L1210 cells, both in vitro using a colony-cloning assay and in vivo in mice, was not statistically different. Thus, although the carbamoylating activity of GMNU is associated with a delay in repair of single-strand breaks, the antitumor activity of this drug is not significantly increased by either the carbamoylating activity or the delay in repair of alkylated lesions. The similar alkylating activity, single-strand breaks, and L1210 cytotoxicity of streptozotocin and GMNU suggest that alkylating activity is the principal mediator of L1210 cytotoxicity.

1 This investigation was supported in part by American Cancer Society Research Grant CH-13, and NIH Grant 1-RO1-CA-17583-02ET.

2 To whom requests for reprints should be addressed.

Received 5/30/78. Accepted 9/29/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.